Tin tức & Cập nhật
Xem bài viết Nhãn khoa
Xem
Chỉ hiển thị Multimedia

Tirzepatide lowers risk of diabetic retinopathy, complications
03 Jun 2026
bởiStephen Padilla
Treatment with tirzepatide, compared with lifestyle intervention alone, helps prevent the incidence of new or progressive diabetic retinopathy (DR) and its complications among patients with diabetes and overweight or obesity, suggests a study.
Tirzepatide lowers risk of diabetic retinopathy, complications
03 Jun 2026
96-week PULSAR data support aflibercept 8 mg for nAMD
29 May 2026
bởiAudrey Abella
Updated results from the phase III PULSAR trial show that intravitreal (IVT) aflibercept 8 mg, when administered at extended dosing intervals of up to 20 weeks, led to visual gains and anatomic improvements comparable to the 2-mg dose, with no new safety concerns over 96 weeks, in treatment-naïve individuals with neovascular age-related macular degeneration (nAMD).







